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Background: Demonstration of duodenal periampullary lesions, especially small tumors,
is difficult with many imaging modalities, such as abdominal ultrasonography (US),
abdominal computed tomography (CT), percutaneous transhepatic cholangiography (PTC)
and endoscopic retrograde cholangiopancreatography (ERCP) and/or magnetic resonance
cholangiopancreatography (MRCP). Endoscopic ultrasonography (EUS) provides good imaging
results for the ampullopancreatic region. This study presents a clinical assessment of EUS
for periampullary lesions.
Patients and Methods: A total of 12 patients who had periampullary lesions studied
by abdominal US, abdominal CT, PTC, ERCP, and/or MRCP all underwent this EUS study.
Eleven patients received surgical treatment and one received endoscopic papillotomy with
stone retrieval. The surgical findings and pathologic diagnoses in their final states were
compared with the EUS findings.
Results: Among nine ampullary small tumors (mean size, 1.7 cm; range, 0.9–2.5 cm),
EUS produced a good demonstration of small ampullary tumors, obtaining accuracy of
tumor invasion of 88.9% (8/9). EUS found small stones at the distal common bile duct
(CBD) in five cases that were not shown on the other imaging modalities. However, EUS
failed to detect an ampullary tumor with stent in place and could not delineate a coexisting
hilar tumor invading the common hepatic duct.
Conclusion: EUS is an accurate tool for the diagnosis and staging of small ampullary
tumor (< 3 cm) with local invasion, and for stones in the distal CBD. However, EUS
has its limitations in ampullary tumors with stent in place and in the finding of coexisting
liver hilar tumors. Nevertheless, EUS is an important imaging modality in aiding the
diagnosis and treatment decisions for periampullary lesions.
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Introduction
Periampullary lesions including ampullary cancer,
pancreatic cancer, focal pancreatitis, impacted dis-
tal common bile duct (CBD) stones, and distal CBD
cancer can manifest jaundice due to biliary obstruc-
tion. The treatment of periampullary lesions varies
depending on the causes. Therefore, the diagnosis
of periampullary lesions is important. Sometimes,
the imaging studies of abdominal ultrasonography
(US), abdominal computed tomography (CT), and
endoscopic retrograde cholangiopancreatography
(ERCP) cannot provide sufficient evidence for diag-
nosis and treatment decisions, especially when the
periampullary lesion is small. Endoscopic ultrasono-
graphy (EUS) produces high-resolution images with
delineation of the ampullopancreatic region, im-
proving the estimation of these lesions [1–3].
Ampullary carcinoma has a more favorable prog-
nosis than either pancreatic carcinoma or chol-
angiocarcinoma, and those in stage I of the TNM
classification have high survival rates [4]. EUS has
been reported to provide accurate regional staging,
leading to appropriate therapy [5]. Recently, several
authors have agreed that EUS demonstrates high
accuracy in diagnosing choledocholithiasis, espe-
cially demonstrating tiny stones in the distal CBD
[5–8]. Therefore, EUS has the ability to differenti-
ate among periampullary lesions. In this study, we
collected cases of periampullary lesions and eva-
luated the efficiency of diagnosis by EUS.
Patients and Methods
From January 2001 to October 2002, 12 patients
who were suspected of having a periampullary le-
sion by clinical presentation and imaging studies
were collected. The imaging studies included ab-
dominal US, abdominal CT (Volume Zoom; Siemens,
Munich, Germany), ERCP (Diagnost 96; Philips,
Eindhoven, The Netherlands), magnetic resonance
cholangiopancreatography (MRCP) (Gyroscan
Intera; Philips), and/or percutaneous transhepatic
cholangiography (PTC) (Diagnost 96; Philips). There
were four males and eight females, with a mean
age of 63.8 years (55.5 years in males; 68 years
in females). EUS was performed by the Olympus
EU-M30 with an Olympus GF-UM240 endosono-
scope (Olympus; Tokyo, Japan). Eleven patients
received surgical treatment, and one received endo-
scopic papillotomy with stone retrieval. Specimens
from operation were sent for pathologic examina-
tion. The findings from abdominal US and CT, ERCP/
MRCP and EUS were studied. The surgical findings
and pathologic diagnoses in their final states were
compared with the EUS findings. Patients were
clinically followed-up for at least 7 months (mean,
29.1 ± 13.5 months; range, 7–40 months), except
for one patient who died of surgical complications
1 month after a Whipple operation.
Results
The findings from EUS, CT and ERCP/MRCP in the
12 patients are shown in Table 1. Eight patients
(cases 1–8) had the clinical manifestation of ob-
structive jaundice. Their abdominal US revealed dif-
fuse biliary tract dilatation. Abdominal CT could
not detect ampullary lesions or definite invasion
in these eight cases (Fig. 1B). ERCP studies showed
papillary tumors or papillary edema in these eight
cases. Biopsies were taken from ampullary lesions
for pathologic examination. Adenocarcinoma was
documented in seven patients (cases 1–6, 8), and
inflammatory change was noted in the other patient
(case 7). ERCP/MRCP showed distal CBD obstruc-
tion in these eight patients, although it failed to
elucidate the invasion of cancers. Endoscopic retro-
grade biliary drainage (ERBD) was administered
for biliary obstruction in case 7. EUS revealed that
the tumor in cases 1–4 and 8 were limited to the
ampulla of vater (T1), and the tumors in cases 5
and 6 invaded the pancreas (T3). The mean dia-
meter of these tumors as measured by EUS was
1.7 ± 0.5 cm (range, 0.9–2.5 cm). Among the seven
adenocarcinoma patients, EUS also showed stones
within the CBD in two patients (cases 4 and 5;
6.4 mm and 6.6 mm in size, respectively). The small
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stones were not demonstrated on either abdomi-
nal CT or ERCP. In case 7, EUS only revealed a
heterogeneous parenchymal change of the pan-
creatic head and no definite tumor at the papilla,
but thickened distal CBD wall with a plastic stent
in place (Fig. 2C). Owing to biliary obstruction of
uncertain etiology, surgical intervention was per-
formed, and the frozen section showed adenocar-
cinoma. Subsequently, Whipple pancreaticoduo-
denectomy was performed as a curative treatment.
In total, seven patients (cases 1–7) received Whipple
pancreaticoduodenectomy. One patient (case 8)
received wedge resection of the tumor because of
liver cirrhosis and the limited invasion (T1) of EUS
staging.
In a 47-year-old male (case 12), abdominal US
revealed biliary dilatation. ERCP found a big pap-
illary tumor. EUS found a 2.5-cm papillary tumor
(T1) and enlarged lymph node (N1) beside the
CBD. Adenocarcinoma was proven by pathology.
MRCP revealed both a papillary tumor and a hilar
tumor with biliary duct stricture. The Whipple pro-
Abdominal CT
CBD dilatation,
normal PD
CBD and PD
dilatation, stent
in CBD
CBD dilatation,
normal PD
CBD dilatation,
normal PD
CBD and PD
dilatation,
CBD stones
CBD and PD
dilatation
CBD dilatation,
chronic pancreatitis
CBD dilatation,
normal PD
CBD dilatation,
normal PD
CBD dilatation,
normal PD
CBD dilatation,
normal PD
Papillary tumor, CBD
dilatation, normal PD
MRCP / ERCP with biopsy
Distal CBD obstruction,
ampullary tumor / nil
Distal CBD obstruction,
ampullary tumor /
adenocarcinoma
Distal CBD obstruction /
inflammation
Distal CBD obstruction,
ampullary tumor / nil
Distal CBD obstruction,
ampullary tumor /
adenocarcinoma
Distal CBD and PD
dilatation / nil
Distal CBD obstruction
with CBD dilatation /
inflammation
Distal CBD obstruction /
inflammation
CBD dilatation
CBD dilatation and
choledochocele
CBD dilatation
Papillary tumor, hilar
tumor / adenocarcinoma
EUS
Tumor limited to papilla
Size: 2.1 cm
Tumor limited to papilla
Size: 1.3 cm
Tumor limited to papilla
Size: 0.9 cm
Tumor limited to papilla
Size: 1.5 cm, CBD stones
Tumor invades papilla and
pancreas
Size: 2.4 cm, CBD stones
Tumor invades papilla and
pancreas
Size: 1.6 cm
Pancreatic head
heterogeneous change
Stent in CBD
Tumor limited to papilla
Size: 2.0 cm
CBD stones, 1.0 cm
CBD stones
CBD stone
Tumor limited to papilla
Size: 2.5 cm, LN(+)
Table 1. Imaging findings from abdominal computed tomography (CT), magnetic resonance
cholangiopancreatography (MRCP) / endoscopic retrograde cholangiopancreatography (ERCP), and
endoscopic ultrasonography (EUS), and pathology findings in 12 patients
Case Pathology staging
1 Ampullary
adenocarcinoma,
1.8 cm, T1N0
2 Adenocarcinoma,
2.3 cm, T2N0
3 CBD stone
4 Adenocarcinoma, T2
5 Adenocarcinoma, T3
6 Adenocarcinoma, T3
7 Adenocarcinoma, T3
8 Adenocarcinoma, T2N0
9 CBD stone
10 CBD stone
11 CBD stone
12 Adenocarcinoma, T3N1
CBD = common bile duct; PD = pancreatic duct; LN = lymph node.
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cedure was performed, and pathology showed ad-
enocarcinoma at the papilla and liver hilum with
lymph node metastasis. The duodenal wall and
pancreas were free from malignancy. This patient
died of recurrent biliary tract infection 40 months
after operation. Overall, the detection rate of am-
pullary tumors was 88.9% (8/9), and the accuracy
in delineating tumor invasion was 88.9% (8/9) by
EUS (Table 2).
Three female patients (cases 9–11) had the clin-
ical symptoms of abdominal pain and jaundice.
Abdominal US and abdominal CT revealed biliary
tract dilatation. ERCP found a bulge over the pap-
illa with normal mucosa in these three cases. In case
10, cholangiography by ERCP showed choledo-
chocele. The other two patients received MRCP,
which showed biliary tract dilatation (Fig. 3B). EUS
found small stones in these three patients (6.3 mm,
10 mm and 12 mm in size, respectively) in the distal
CBD (Fig. 3C). Case 10 received papillotomy and
stone retrieval. The other two underwent surgical
stone removal. EUS demonstration of distal CBD
stones was 100% (5/5) (Table 2).
Discussion
When obstructive jaundice is suspected in clinical
Fig. 1. Case 7: (A) endoscopic retrograde cholangiopancreatography reveals no tumor at the papilla (arrow); (B) abdominal
computed tomography scan shows no definite mass around the papilla (arrow); (C) endoscopic ultrasound shows a hypoechoic
mass, about 2.5 × 1.5 cm in diameter, without local invasion.
  A B C
Fig. 2. (A) Endoscopic retrograde biliary drainage (ERBD) tube (arrow) is in place for biliary obstruction. (B) Endoscopic
retrograde cholangiopancreatography demonstrates the narrowing of the distal common bile duct (arrow). (C) Endoscopic
ultrasound shows the hypoechoic, thickened wall of the distal common bile duct (arrow) with the ERBD tube in the center
(two hyperechoic spots).
  A B C
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practice, noninvasive procedures such as abdomi-
nal US and/or CT are usually the diagnostic tools
used to determine the cause. If the obstructive lesion
is located in the periampullary region, dilatation of
the CBD and/or main pancreatic duct may be the
only findings, especially in cases of small lesions.
ERCP and MRCP are the most often used options
for further surveillance. ERCP and MRCP are both
able to provide accurate information on the ducts
of the pancreaticobiliary system, and to detect duc-
tal invasion by the obstructive lesion. At the same
time, tissue biopsy from the prominent ampulla
of vater can be performed via ERCP for pathologic
study. However, the extent of local invasion is usu-
  A B C
Fig. 3. (A) Endoscopic retrograde cholangiopancreatography shows an enlarged papilla (arrow). (B) Magnetic resonance
cholangiopancreatography shows a diffusely dilated common bile duct. No filling defect is present (arrow). (C) Endoscopic
ultrasound demonstrates a small stone (arrow) in the distal common bile duct.
Table 2. Different imaging modalities compared with pathologic results
Endoscopic US Abdominal CT Abdominal US
n (%) n (%) n (%)
Pathologic results
Ampullary cancer (n = 9)
Tumor detection .8/9 (88.9) 0.1/9 (11.1) 0/9 (0)
Tumor invasion .7/9 (77.8) 0.1/9 (11.1) 0/9 (0)
Limited to duodenal wall (n = 5) 5/5 (100) 0/5 (0)0 0/5 (0)
Infiltration into pancreas (n = 4) 2/4 (50)0 1/4 (25) 0/4 (0)
Metastatic LN detection (n = 1) 1/1 (100) 0/1 (0)0 0/1 (0)
CBD stone detection (n = 5) 5/5 (100) 0/5 (0)0 0/5 (0)
ally delineated by ERCP and MRCP with difficulty
in small periampullary lesions. Furthermore, the
nature of the periampullary lesion cannot be deter-
mined, especially when the pathologic examination
reveals a nonmalignant finding. Deciding whether
a surgical approach is appropriate or not then
becomes very difficult.
Since the introduction of EUS, small periampul-
lary lesions have not been a tough problem. EUS
is superior to abdominal US and CT in detecting
and staging small periampullary tumors [3]. Fur-
thermore, EUS can demonstrate the CBD and pan-
creatic duct, and detect ductal invasion as well
as ERCP and MRCP. EUS has been reported to be
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superior to ERCP, with a lower cost, higher diag-
nostic yield, and lower rate of complications [9,10].
While MRCP has a good demonstration of the bili-
ary tree, it has a lower sensitivity in detecting CBD
stones [10,11] and a higher cost than EUS in Taiwan.
In our series of nine ampullary cancers (mean
size, 1.7 cm; range, 0.9–2.4 cm), EUS produced
good demonstration in contrast to abdominal US,
abdominal CT, ERCP and/or MRCP. EUS had an
87.5% (7/8) accuracy in diagnosing local invasion
in the eight small ampullary cancers, leading to the
decision to perform a Whipple operation. Although
the Whipple operation had a mortality rate of 5%,
the operation was performed as a curative surgi-
cal treatment for ampullary tumors [12,13]. Some
authors have mentioned that local tumor resection
is still suitable for patients with major underlying
disease or for elderly patients [12–15], and there
was no difference between local tumor resection
and Whipple pancreaticoduodenectomy in sur-
vival analysis [13,14]. The accuracy of tumor in-
vasion was 77.8% (7/9) in our series. Understaging
of local invasion by EUS occurred in two cases of
tumor invasion to the pancreas (T3). One 72-year-
old female patient (case 12) with liver cirrhosis
received local resection after an EUS staging of
T2N0. However, surgical pathology revealed pan-
creatic invasion (T3N0). The understaging in this
case might have been due to peritumoral inflam-
mation, as reported before [3]. A 74-year-old woman
(case 7) had acute pancreatitis and received a plastic
stent for distal CBD stricture. Because of the inter-
ference of the stent in place and pancreatitis [3,16],
EUS underestimated the ampullary tumor (Fig.
2C). It has also been reported that the presence
of a stent at the papilla interferes with EUS imaging,
resulting in poor demonstration of the papillary
region [3].
Three cases of CBD stones and two cases of
ampullary cancer combined with CBD stones were
underestimated by abdominal CT and ERCP and/
or MRCP. EUS showed distal CBD stone in all cases,
which were confirmed by operation. With small
stones in a large CBD lumen, ERCP and/or MRCP
may result in a false-negative diagnosis [13]. EUS
is more sensitive in the diagnosis of choledocho-
lithiasis, especially with small stones in a dilated
CBD [5–8].
EUS has difficulty in assessing the hilar region
and the right side intrahepatic ducts [16]. When
obstructive jaundice is caused by a combination of
hilar and papillary lesions, EUS is insufficient for
diagnosis and staging, and may lead to inadequate
information for surgical treatment.
In conclusion, EUS is an accurate tool for the
diagnosis of periampullary tumors and local stag-
ing of small ampullary tumors (< 3 cm). Although
EUS has limitations, such as the limited range of
the high-frequency ultrasound beam and limita-
tions in tissue parenchyma differentiation, EUS is
an important imaging tool for aiding the diagnosis
and deciding on the modality of treatment for
periampullary lesions.
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